Successors Persons Entitled to Benefit of Agreement Clause Example from Business Contracts

This example Successors Persons Entitled to Benefit of Agreement clause appears in 7 contracts from 1 company

Successors Persons Entitled to Benefit of Agreement. This Agreement shall inure to the benefit of and be binding upon the several Underwriters, the Company, and their respective successors and assigns. Notwithstanding the foregoing, the determination as to whether any condition in Section 6 hereof shall have been satisfied, and the waiver of any condition in Section 6 hereof, may be made by the Representatives in their sole discretion, and any such determination or waiver shall be binding on each of the Underwriters and shall not require the conse...nt of any Underwriter. Nothing expressed or mentioned in this Agreement is intended or shall be construed to give any person, other than the persons mentioned in the preceding sentences, any legal or equitable right, remedy or claim under or in respect of this Agreement, or any provisions herein contained, this Agreement and all conditions and provisions hereof being intended to be and being for the sole and exclusive benefit of such persons and for the benefit of no other person; except that the indemnities of the Company contained in this Agreement shall also be for the benefit of the Underwriter Indemnified Parties and the several indemnities of the Underwriters shall be for the benefit of the Company Indemnified Parties. It is understood that each Underwriter's responsibility to the Company is solely contractual in nature and the Underwriters do not owe the Company, or any other party, any fiduciary duty as a result of this Agreement. View More Arrow
Found in Sarepta Therapeutics, Inc. contract
Sarepta Therapeutics, Inc. Contracts

Underwriting Agreement, March 5, 2019 among Sarepta Therapeutics, Inc. and Goldman Sachs & Co. LLC and Morgan Stanley & Co. LLC, as representatives of the underwriters named... (Filed With SEC on March 7, 2019)

Underwriting Agreement, October 13, 2021 among Sarepta Therapeutics, Inc. and Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC, Morgan Stanley & Co. LLC and Credit Suisse... (Filed With SEC on October 15, 2021)

Underwriting Agreement, dated November 8, 2018, among Sarepta Therapeutics, Inc. and Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC and Credit Suisse Securities (USA) LLC, as... (Filed With SEC on November 9, 2018)

2,102,000 Shares SareptaTherapeutics, Inc. Common Stock ($0.0001 par value) EQUITYUNDERWRITING AGREEMENT (Filed With SEC on June 10, 2016)

2,650,000Shares Sarepta Therapeutics, Inc. Common Stock ($0.0001 par value) EQUITY UNDERWRITING AGREEMENT (Filed With SEC on April 24, 2014)

3,250,000 Shares SareptaTherapeutics, Inc. Common Stock ($0.0001 par value) EQUITYUNDERWRITING AGREEMENT (Filed With SEC on October 6, 2015)

7,650,000 Shares SareptaTherapeutics, Inc. Common Stock ($0.0001 par value) EQUITYUNDERWRITING AGREEMENT (Filed With SEC on July 26, 2017)